OSI Pharmaceuticals Inc.

Public Company, Headquarters Location
41 Pinelawn Rd., Melville, NY 11747-3149, United States
(631)962-2000, (631)752-3880 fax, http://www.osip.com

Primary SIC: In Vitro & In Vivo Diagnostic Agents, Primary NAICS: In-Vitro Diagnostic Substance Manufacturing
Description: Manufacturing: Research and development of pharmaceutical drugs for diseases including cancer, atherosclerosis, neurological disorders and chronic anemias.

View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!

OSI Pharmaceuticals Inc., News and Information

OSI Pharmaceuticals Sets R&D Analyst Day Webcast
Wireless News; 12/7/2009; 309 words; ...Wireless News 12-07-2009 OSI Pharmaceuticals Sets R&D Analyst...NewsOSI Pharmaceuticals, Inc. has announced that it...Officer, and members of OSI's management team...2009 Close-Up Media, Inc. All Rights Reserved...

FORM 8-K: OSI PHARMACEUTICALS ANNOUNCES OTHER EVENTS
US Fed News Service, Including US State News; 12/5/2009; 1065 words; WASHINGTON, Dec. 4 -- OSI PHARMACEUTICALS, INC., Melville, N.Y., files Form 8-K (current...of registrant as specified in its charter is OSI PHARMACEUTICALS, INC. Other Events On December 3, 2009, Colin Goddard...

Conference Calls Today: 12:30-2:20 P.M. EDT.
Investrend; 12/3/2009; 917 words; ...today at 12:30 to 2:20 p.m. include: OSI Pharmaceuticals Inc. (NASDAQ: OSIP), Watts Water Technologies Inc. (NYSE: WTS), Toll Brothers Inc. (NYSE: TOL), Sprint Nextel Corporation...

OSI Pharmaceuticals Announces Tarceva to Be Reviewed by the FDA's Oncologic Drugs Advisory Committee for Use as a First-Line Maintenance Therapy in Advanced Non-Small Cell Lung Cancer.
Cancer Weekly; 12/1/2009; 1289 words; ...the treatment of cancer (see also OSI Pharmaceuticals, Inc.). In June 2009, the FDA accepted...Non-Small Cell Lung Carcinoma, OSI Pharmaceuticals Inc., Oncology, Pancreas, Pharmaceutical, Pharmaceutical Business, Pharmaceutical...

NewCo News: Scripps Spinout Xcovery Sees Room for Kinase Improvement.
BIOWORLD Today; 12/1/2009; 1117 words; ...about a third of all pharmaceutical discovery efforts...and CEO of Xcovery Inc., would argue the...sorafenib, Onyx Pharmaceuticals Inc. and Bayer AG...sunitinib, Pfizer Inc.), Tarceva (erlotinib, OSI Pharmaceuticals Inc...

Why Purchase This Company Profile?

  • Sales prospecting
  • Competitive analysis
  • Vendor & supplier evaluation
  • Customer evaluation and analysis
  • Strategic planning

Need More Information?

Start a new search

Tell Us What You Think

Take our short survey to tell us what would make Goliath more valuable to you.

Add Your Company Information to Goliath
If your company does not appear in Goliath, click here to add it.

Update Your Company Information
If your company information has changed or is not correct,
click here to let us know.